WB Blends

WB Blends is a US-based company specializing in the manufacturing of nutraceuticals, providing a diverse array of products designed to support various health needs, including custom formulations in liquid, capsule, and powder forms. Founded in 1995 and headquartered in Spanish Fork, US, WB Blends focuses on the production of nutraceuticals. The company was established by individuals with a background in the health industry, positioning itself as a key player in custom supplement manufacturing. WB Blends has primarily operated without significant pivots or changes in business strategy and does not have any known subsidiaries.

In February 2026, WB Blends was acquired by The Riverside Company, although specific financial terms were not disclosed. This acquisition aims to bolster its product development within the pharmaceutical sector. WB Blends specializes in the manufacturing of nutraceuticals, offering a comprehensive range of products including liquid, capsule, and powder formulations. Their core offerings support diverse health needs and include high-quality gelatin, pullulan, and HPMC vegetarian capsules, alongside a variety of custom powder supplements and liquid formulations such as tinctures and syrups.

With a focus on meeting specific dietary and regulatory requirements, WB Blends accommodates non-GMO, gluten-free, organic, kosher, and halal certifications, ensuring broad consumer appeal and compliance. The company serves a diverse client base, including supplement brands and private-label customers, across various geographical markets, primarily in North America, Europe, and Asia, catering to the increasing demand for health and wellness products that align with consumer preferences. WB Blends engages in B2B transactions, primarily partnering with supplement brands and retailers to manufacture custom formulations. The revenue structure is built around turnkey and tolling services, where clients provide specific formulations and WB Blends handles production, packaging, and quality control.

While specific pricing details are proprietary, the company emphasizes efficient lead times of 8-12 weeks and a commitment to 99%+ on-time delivery, which enhances customer satisfaction and repeat business. The company’s extensive experience and certifications, including cGMP and FDA compliance, further solidify its position within the industry, enabling it to maintain strong relationships with clients looking for reliable manufacturing solutions in the nutraceutical space. Following the acquisition by The Riverside Company in February 2026, WB Blends plans to enhance its product development, specifically targeting innovations in the pharmaceutical sectors. The company aims to introduce several new products designed to meet evolving health needs, although specific release dates have not been disclosed.

Additionally, WB Blends is working on expanding its market presence into new regions, with plans to target Europe and Asia more aggressively by the end of 2026. The resources obtained through the acquisition will be utilized to support these growth initiatives, facilitating the development and launch of new products.